Primary human bone marrow megakaryocytes were studied for their ability to express and release cytokines potentially relevant to their proliferation and/or differentiation. The purity of the bone marrow megakaryocytes was assessed by morphologic and immunocytochemical criteria. Unstimulated marrow megakaryocytes constitutively expressed genes for interleukin-la (IL-lp), IL-6, granulocyte-macrophage colony-stimulating factor (GM-CSF), and tumor necrosis factor-cr (TNF-a), by the polymerase chain reaction (PCR) and Northern blot analysis. At the protein level, megakaryocytes secreted significant amounts of IL-1/3 (53.6 f 3.6 pg/mL), 11-6 (57.6 ? 15.6 pg/mL). and GM-CSF (24 f 4 pg/ mL) but not TNF-cr. Exposure of human marrow megakaryocytes to IL-1p increased the levels of IL-6 (87.3 f 2.3 pg/mL) EMATOPOIETIC CELLS of myeloid and lymphoid lineages are known to be important sources of a variety of cytokines. Release of cytokines, such as colony stimulating factors and interleukins, during basal conditions and as part of the inflammatory response is believed to contribute to modulation of hematopoiesis. Relatively little is known about the capacity of cells of megakaryocytic lineage to elaborate ~ytokines."~ We have shown previously that cyba megakaryoblastic cell line (CMK) cells, a permanent human megakaryocytic cell line, were found to constitutively express moderate mRNA levels for tumor necrosis factor-a (TNF-a), transforming growth factor-8 (TGF-P), interleukin-lp (IL-lp), and endothelial cell growth factor (ECGF) transcripts.' After treatment with the phorbol ester PMA, gene expression for IL-la, IL-6, granulocyte-macrophage colony-stimulating factor (GM-CSF), and IL-3 was increased. In addition, we observed that phorbol-12-myristate-13-acetate (PMA)-stimulated CMK cells synthesized low levels of TNF-a and IL-6 and higher levels of GM-CSF, ILlp, and IL-la protein^.^ Although permanent megakaryocytic cell lines, such as CMK, derived from patients with megakaryoblastic leukemia, appear capable of elaborating a wide repertoire of cytokines, the physiologic significance of such observations is unclear because the biology of permanent transformed cell lines may not reflect that of primary nontransformed cells.
EMATOPOIETIC CELLS of myeloid and lymphoid lineages are known to be important sources of a variety of cytokines. Release of cytokines, such as colony stimulating factors and interleukins, during basal conditions and as part of the inflammatory response is believed to contribute to modulation of hematopoiesis. Relatively little is known about the capacity of cells of megakaryocytic lineage to elaborate ~ytokines."~ We have shown previously that cyba megakaryoblastic cell line (CMK) cells, a permanent human megakaryocytic cell line, were found to constitutively express moderate mRNA levels for tumor necrosis factor-a (TNF-a), transforming growth factor-8 (TGF-P), interleukin-lp (IL-lp), and endothelial cell growth factor (ECGF) transcripts.' After treatment with the phorbol ester PMA, gene expression for IL-la, IL-6, granulocyte-macrophage colony-stimulating factor (GM-CSF), and IL-3 was increased. In addition, we observed that phorbol-12-myristate-13-acetate (PMA)-stimulated CMK cells synthesized low levels of TNF-a and IL-6 and higher levels of GM-CSF, ILlp, and IL-la protein^.^ Although permanent megakaryocytic cell lines, such as CMK, derived from patients with megakaryoblastic leukemia, appear capable of elaborating a wide repertoire of cytokines, the physiologic significance of such observations is unclear because the biology of permanent transformed cell lines may not reflect that of primary nontransformed cells.
The repertoire of cytokines elaborated by primary human bone marrow megakaryocytes has not yet been elucidated. We have previously shown that stimulated human marrow megakaryocytes expressed mRNA for IL-1p. 6 In addition, Navarro et a1' observed IL-6 expression and production in primary isolated megakaryocytes. To address the question of which cytokines may be released by primary bone marrow megakaryocytes, we employed highly sensitive and specific cytokine radioimmunoassays. Human bone marrow megakaryocytes were found to be capable of releasing certain cytokines, among them hematopoietic growth factors capable of modulating megakaryocytopoiesis. Moreover, the secreted cytokines acted additively to increase the number of megakaryocyte colony-forming unit (Cm-MK) colonies. These observations suggest that marrow megakaryocytes may participate in an autocrine loop operative in the regula- tion of megakaryocytopoiesis, as well as serve as sources for cytokines, which can modulate the growth and maturation of cells of other hematopoietic lineages.
MATERIALS AND METHODS
Growth factors. Human kit ligadstem cell factor (KUSCF) was cloned and expressed in Escherichia coli and was provided by Amgen, Inc (Thousand Oaks, CA).'"' Recombinant human IL-3 (rhIL-3). hGM-CSF, hTGF-8, hIL-6, rhIL-18, and TNF-a were obtained from R & D Systems (Minneapolis, MN). These cytokines were determined to be free of endotoxin contamination (see below). Plateau doses of each factor were determined from dose-response curves and used in cultures at the following final concentrations: W S C F 100 ng/mL; IL-6 10 ng/mL; TGF-8 10 ng/mL; IL-18 10 ng/mL; IL-3 10 ng/mL; and GM-CSF 200 ng/mL.
Detection and quantitation of endotoxin. The cytokines used in this study were tested for endotoxin contamination by using E-TOXATE kit (Limulus Amebocyte Lysate; Technical Bulletin No. 210; Sigma, St Louis, MO). The lower limit of detection was determined to be 0.05 to 0.1 endotoxin units (EU). Preparation of PMA-treated megakaryocytic cells. PMA (Sigma) was dissolved in dimethylsulfoxide (DMSO) and stored at -80°C. Just before use, PMA was diluted in the RPM1 culture medium. Megakaryocytic cells were incubated with PMA at a concentration of 10 ng/mL in a 5% CO2 humidified atmosphere as indicated.
Marrow megakaryocytes. Human bone marrow was obtained by aspiration from the iliac crest of normal donors who gave informed consent in a protocol approved by the New England Deaconess Hospital Institutional Review Board. The marrow was aspirated into preservative-free heparin (Sigma) and separated by centrifugation through Ficoll-Hypaque (Pharmacia, Piscataway, NJ) at 1,200g at room temperature for 30 minutes. After two washes with sterile 1 X phosphate-buffered saline (PBS), the cells were resuspended in Iscove's modified Dulbecco's medium (IMDM) with 20% fetal calf serum (FCS), penicillidstreptomycin (P/S) and L-glutamine; seeded onto T-75 tissue culture flasks (Coming, Coming, NY); and incubated at 37°C in 5% CO,. After 24 hours, the nonadherent cells were gently removed. Human marrow megakaryocytes were isolated by a method employing immunomagnetic beads using antihuman glycoprotein GpIIb/llIa monoclonal antibody (MoAb) as described previously. 6 The cells that rosetted with immunomagnetic beads were collected with a dynal magnetic particle concentrator (Dynabeads M-450; Dynal Inc, Great Neck, NY) washed 3 times with megakaryocyte (MK) medium, which consisted of CaZ'-Mg2' free PBS containing 13.6 mmol/I-sodium citrate, 1 mmol/L theophylline, 1 % bovine serum albumin (BSA), fraction V (Sigma), and 11 mmol/ L glucose, adjusted to pH 7.3 and an osmolarity of 290 mOSM/ L. After purification, cells were labeled by an MoAb against von Willebrand factor (MoAb 4F9; AMAC Inc, Westbrook, ME) and more than 97% of the cells were stained. Twenty milliliters of bone marrow aspirate generally yielded about 1 X 10' megakaryocytes. For RNA preparation, bone marrow cells were first depleted from the adherent cells and purified by the two-layer immunomagnetic bead technique. Cells were fresh frozen and pooled to a total number of about IO6 from which RNA was prepared. Contaminating cells (1 % to 5%) were essentially monocytes and macrophages. Cells were cultured in RPMI 1640 supplemented with 2% platelet-poor plasma (PPP)" at 37°C in a 5% CO, fully humidified atmosphere for 24 hours in the presence or absence of growth factors as indicated in the text. The bone marrow megakaryocyte cultures were tested for the presence of contaminating cell populations after 24 hours incubation. Monocytes and macrophages were identified by morphology after May-Grunwald-Giemsa staining and by positive antibody staining using MoAb directed against CD14 (monocytes), CD15 (granulocytes), CD16 (IgG Fc receptor-natural killer [NK] cells, granulocytes, and macrophages). These analyses indicated that the maximum potential degree of contamination of bone marrow megakaryocytes after 24 hours was about 5% to 10%.
Megakaryocyte progenitor assay. Bone marrow low-density cells were cultured in a semisolid medium using the plasma clot technique? The medium consisted of RPMI 1640, 1% deionized BSA, 20 pg/mL asparagine, 28 pg/mL CaCI,, 10% of PPP plus rhIL-3 (100 U/mL), and 2.5 X 10' nonadherent bone marrow cells. Citrated bovine plasma (GIBCO, Gaithersburg, MD) (10%) was added as the last product. PPP and citrated bovine plasma used in these cultures were assayed and determined to be devoid of any detectable IL-6 or endogenous TGF-P. Conditioned medium of primary megakaryocytes was prepared from cultures of bone marrow megakaryocytes (105/mL) cultures in RPMI 1640 + 2% PPP. The supernatant was collected after 24 hours of culture, centrifuged, and concentrated (~10-fold). This conditioned medium was tested, in a final concentration of 25% (vol/vol), for its effect on CFU-MK colonies. Culture medium in 1 mL was pipetted into 35-mm petri dishes and allowed to clot. Cultures were incubated for 12 days at 37°C in duplicate. Quantitation of colonies was performed by an indirect immunofluorescent labeling using anti-GpIIIa antibodies. Each dish was entirely scanned under a fluorescent microscope at day 12 of culture, and each cluster of three or more megakaryocytes was scored as a colony.
Cytokine expression analysis. To assay expression of specific cytokine genes, total cellular RNA was extracted from the isolated primary bone marrow megakaryocytes. The RNA was extracted by the guanidine-isothiocyanate procedure, followed by ultra-centrifugation through a CsCl cushion. Total RNA was run on a 1.2% formaldehyde agarose gel, and the intact RNA was visualized by ethidium bromide staining. Reverse transcription (RT) of RNA was performed using 2 pg of total RNA from each sample, and polymerase chain reaction (PCR) assays for each primer set were performed according to Clontech's Cytokme Mapping PRIMATE methods (Clontech Laboratories, Inc, Palo Alto, CA). The following human primer sets were used: IL-10 (81 1 bp), IL-6 (636 bp), GM-CSF (420 bp), TNF-a (691 bp), and actin primer set (584 bp, 300 bp, 100 bp).
The PCR products for each set were analyzed on a 2% agarose gel (BRL, Bethesda, MD). The amplified DNA bands were visualized with a UV transilluminator. Amplified DNA could be detected at the expected size by ethidium bromide staining of the gel. Internal reaction standards for PCR controls were performed for each set of primers, which included RNA with or without primers, primers without RNA, and RNA with actin primers. All the primer stocks and total preparation of RNAs were analyzed to exclude contamination by cellular DNA. First-strand DNA synthesis and PCRs were performed as described. 5 Northern blot analysis. Total cellular RNA was extracted from bone marrow megakaryocytic (10') cells according to the 4 mol/L guanidine-isothiocyanate method. Twenty micrograms of RNA per lane was electrophoresed in 1 % agarose gel with 2.2 mol/L formaldehyde and transferred to nylon filters (Hybond-N; Amersham CO, Arlington Heights, IL). Filters were hybridized with labeled radioactive complementary DNA inserts at 37°C in the presence of 50% formamide, 3 X SSC, 0.5% sodium dodecyl sulfate (SDS), 10% dextran sulphate, and 100 pg/mL denatured salmon sperm DNA. Filters were washed at 60°C for 2 hours in 0.2 X SSC (sodium chloride and sodium citrate), 0.5% SDS. Membranes were then exposed to Kodak Xomat films (Eastman Kodak, Rochester, NY) for 48 hours. The specific messenger RNA (mRNA) transcripts were detected with the human cDNA probes for different cytokines (TNFa , GM-CSF, IL-lP, and IL-6).
Cytokine assays. Immunoenzymetric assays for human IL-I p, human GM-CSF, human TNF-a, and human IL-6 were obtained from R & D Systems and used according to the manufacturer's instructions. A standard curve with a cytokine-positive control was run in each assay and the lower limit of detection was determined to be 0.35 pg/mL for IL-6, 1.5 pg/mL for GM-CSF, and 0.3 pg/mL for TNF-a and IL-10.
Culture conditions. To determine constitutive release of cytokine protein by marrow megakaryocytes, the megakaryocytes ( lo5/ mL) were cultured in RPMI 1640 + 2% PPP for 24 hours. PPP was used to minimize the presence of TGF-P in the cultures." Following determination of kinetics of constitutive cytokine release in vitro. in some experiments exogenous PMA or cytokines were added to determine whether cytokine release could be induced. In these experiments, PMA (10 ng/mL), 1L-3 (10 ng/mL), TGF-/3 (10 ng/mL), or KL/SCF (100 ng/mL) were added over 24 hours. Culture supernatants were then assayed by the cytokine assays.
Statistical analysis. The results were expressed as the mean 2 SEM of data obtained from three or more experiments performed in duplicate. Statistical significance was determined using the Student's t-test.
RESULTS
Cytokine gene expression by bone marrow megakaryocytes. The expression of cytokine genes in primary bone marrow megakaryocytes was studied using PCR analysis. Total RNA from bone marrow megakaryocytes was used as a template for reverse transcriptase reactions. PCR was performed using specific primers for IL-lp, GM-CSF, IL- Twenty micrograms of total RNA was analyzed for TNF-CY, IL-lp, 11-6, and GM-CSF transcripts.
6, and TNF-a. Isolated bone marrow megakaryocytes were found to constitutively express specific mRNAs for IL-ID, GM-CSF, IL-6, and TNF-a (Fig IA) . In addition, cytokine mRNA expression was evaluated by Northern blot analysis (Fig IB) . IL-ID, GM-CSF, IL-6, and TNF-a genes were constitutively expressed by bone marrow isolated megakaryocytes. These studies were performed with bone marrow megakaryocytes that were purified by the immunomagnetic bead technique that provided cultures of megakaryocytes with a purity of -95% based on GplIIa staining. The remaining -5% Gpllla-negative cell population was found to be mostly CFU-GM derived colonies. By using a semiquantitative PCR procedure, we were able to exclude the possibility that the 5% contaminating GplIIa-negative cell population was responsible for the detected signal by Northern blot analysis of the Gpllla-positive cells. For this analysis, bone marrow was selected by immunomagnetic beads coated with GplIIa antibodies. Two cell populations were isolated, GpIlla-positive and Gpllla-negative cells. RNA was prepared from both cell types. Two different mixtures of 10% RNA isolated from Gpllla-negative cells were mixed with 90% RNA isolated from GpIIIa-positive cells (mixture A) or 10% RNA isolated from Gpllla-negative cells were mixed with tRNA (mixture B). PCR analysis using specific primers for IL-p, GM-CSF, IL-6, and TNF-a was performed. Positive signal was detected only with mixture A (data not shown), indicating that, indeed, the positive signal by PCR and Northern blot was caused by the presence of megakaryocytic cells and not the contaminating cells. In addition, PCR analysis using specific primers for CD1 Ib, a specific marker for monocytes, macrophages, and granulocytes. was performed.
No signal was detected (data not shown) indicating that the RNA was isolated from highly purified megakaryocytes.
Bone marrow megakaryocytes synthesize and secrete IL-6 in vitro. The cytokine mRNA expression results were confirmed at the protein level by testing the presence of cytokine activity in megakaryocyte cell-conditioned media. Using a specific immunoenzymetric assay, 50 to 60 pg/mL of IL-6 from cultured megakaryocyte supernatants was detected ( Table l) . The addition of IL-ID ( I O ng/mL) or TGF-0 (20 pg/mL) elicited a dose-dependent increase of IL-6 in all Human megakaryocytes (lo5 cellsll mL) were incubated with control medium alone containing 2% PPP (1 mL) or with cytokines for 24 hours. Supernatants were collected and the levels of IL-6 were evaluated by specific ELISA for IL-6 as described in Materials and Methods. Duplicate cultures were established in each experiment. A different human bone marrow was tested in each set of experiments.
Mean -c SEM values from three independent experiments are presented. Indicates statistically significant difference compared with medium controls. cultures examined. IL-6 was detected in the megakaryocyte supernatants as early as 6 hours after IL-1 p and TGF-P treatment and increased during the first 24 hours (Fig 2A) .
Endotoxin contamination of the cytokine preparation would not account for this stimulatory action on IL-6 because all growth factors were determined to be free of endotoxin. IL-lp induced secretion of 85 to 90 pdmL of IL-6, whereas TGF-P induced secretion of about 125 to 130 pg/mL of IL-6. This profile of IL-6 secretion was quantitatively similar among three different assays performed with megakaryocytes isolated from the different donors.
Stimulation of IL-10 secretion by human megakaryocytes. Secretion of IL-lP protein by human megakaryocytes was evaluated by using a specific IL-1P enzyme-linked immuno- Cultures and assay conditions were identical to those for IL-6 stud-* Indicates statistically significant difference compared with meies (see Table 1 ).
dium controls.
sorbent assay (ELISA). Moderate amounts of IL-10 protein (53 5 3 pg/mL) were detected in the supernatants of unstimulated megakaryocytes (Table 2) . KL/SCF, IL-3, GM-CSF, and TGF-P stimulated modestly the secretion of IL-10 (Table 2). PMA was very potent in inducing IL-1P secretion. Kinetic studies showed that the levels of IL-1p were already increased after 6 hours of culture and continued to increase during the 24-hour incubation period (Fig 2B) .
Effects of cytokines and PMA on secretion of TNF-a by megakaryocytes. TNF-a protein was not detected in the supernatants of human megakaryocytes that were either unstimulated or stimulated for 24 hours with KL/SCF, GM-CSF, or TGF-P (Table 3) . Small amounts of TNF-a (about 10 pglmL and 6 pg/mL) were detected in cultures of megakaryocyte supernatants stimulated with PMA or IL-3, respectively.
Stimulation of GM-CSF secretion in human megakaryocytes. GM-CSF were present in small amounts (24 2 4 pg/ mL) in supernatants of unstimulated megakaryocytes (Table  4) . IL-3 modestly stimulated secretion of GM-CSF secretion (about 37 pg/mL). KL/SCF and TGF-@ were more potent and elicited GM-CSF secretion (55 +-16 pg/mL and 44 5 l1 pg/mL, respectively) ( Table 4) . Interestingly, PMA was the most potent agent to induce GM-CSF secretion. GM-CSF was detected in megakaryocyte supernatants after 6 hours of treatment and accumulated during the 24-hour incubation period (Fig 2C) .
Effects of endogenous production qf cytokines on proliferation of primary human megakaryocytes. To address For
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whether the cytokine proteins detected were indeed secreted by primary megakaryocytes and not by other contaminating cells, such as monocytes, we assayed the supernatants of adherent (ie, monocyte-macrophage-enriched) nonmegakaryocyte bone marrow cell populations and nonadherent nonmegakaryocyte cell populations in final concentrations of 10% and 5%, equivalent to the maximum potential degree of contamination. The levels of IL-6, IL-1P, TNF-a, and GM-CSF in these supernatants were similar to the control RPM1 + 2% PPP (data not shown). In addition, to further show that the production of these cytokines was constitutive on the part of bone marrow megakaryocytes, rather than induced by a cytokine(s) elaborated by the -5% to 10% contaminating cells or elaborated by the contaminating cells, a series of experiments was performed with cultures of adherent or nonadherent nonmegakaryocyte bone marrow cell populations. Conditioned media of these cultures in final concentrations of 10% and 5% were tested for the presence of these cytokines. The levels of E-6, IL-1P, TNF-a, and GM-CSF in the supernatants were similar to the controls (data not shown). These results demonstrate that the cytokine proteins were secreted by primary megakaryocytes and not by the contaminating cells.
To evaluate whether endogenous production and secretion of IL-1P, IL-6, and GM-CSF might play a role in the proliferation and maturation of megakaryocytes, the direct effect of megakaryocytic conditioned media on megakaryocyte progenitors was tested. CFU-MK were established in the presence of IL-3 and GM-CSF ( P < .05) ( Table 5 ). The addition of 25% final concentration (voVvol) of megakaryocytic conditioned medium (concentrated 10 times) plus XL-3 or GM-CSF resulted in an increase of about 35% of CFU-MK (Table 5 ). These results suggested that cytokines secreted by primary megakaryocytes may act synergistically to maintain and enhance megakaryocyte colony formation.
DISCUSSION
In this study we aimed to elucidate whether bone marrow megakaryocytes produced cytokines that could act within the context of an autocrine growth pathway. We have observed that cultures of isolated bone marrow megakaryocytes secreted biologically active cytokines (IL-6, GM-CSF, ILlp, and TNF-a). The transcripts of these cytokines were detected in cultured bone marrow megakaryocytes by PCR and Northern blot analyses. These cytokines were also de- 
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Cultures and assay conditions were identical to those for IL-6 studindicates statistically significant difference compared with meies (see Table 1 ). dium control. tected at the protein level. The endogenous production of these cytokines appeared capable of providing megakaryocyte colony-stimulating activity and acted in a synergistic fashion with IL-3 or GM-CSF in CFU-MK formation. It has been previously reported' that human megakaryocytes secrete IL-6, a growth factor that is known to potently augment megakaryocytopoiesis in vitro and in vivo.'2 It is reasonable to consider autocrine production of one or more growth factors modulates the development of cells of hematopoietic lineage in Interestingly, IL-6 production from marrow megakaryocytes was increased by IL-lP and TGF-P stimulation. Similarly, we detected constitutive expression of IL-lP, TNF-a, and GM-CSF. Bone marrow megakaryocytes elaborated low levels of IL-10, which increased modestly with IL-3, KL/ SCF, GM-CSF, and TGF-P treatment of the cells. In addition, marrow megakaryocytes produced GM-CSF, which increased on stimulation with IL-3, KL/SCF, or TGF-@. Our studies on IL-6 elaboration confirmed those of Navarro et a17 that megakaryocytes expressed and released IL-6 in vitro.
The population of marrow megakaryocytes we isolated was capable of releasing in vitro several regulatory cytokines including IL-1P, TNF-a, IL-6, and GM-CSF. Both GM-CSF and IL-6 have been noted to regulate megakaryocytopoiesis in ~i t r o . '~"~ In vivo studies with IL-6 in lower animals and primates have similarly shown that this cytokine may enhance thrombopoiesis. The elaboration of E -6 and GM-CSF by identifiable marrow megakaryocytes suggests that there may be an autocrine mechanism operative in the regulation of cells of this lineage. Furthermore, early acting cytokines, such as KL/SCF, were found to augment release of these growth regulatory cytokines from marrow megakaryocytes.".'a-20 We and others have previously reported that KL/ SCF, a mesenchymal-derived growth factor, is able to potentiate in vitro megakaryocytopoiesis, both at the progenitor (CFU-MK) level and at the megakaryoblast stage.*"" Although KL/SCF could act directly on the megakaryocyte, it is also possible that its effect is mediated secondarily by release of cytokines, such as IL-6, from megakaryocytes. Further experiments designed to block the elaboration of IL-6 in vitro from stimulated megakaryocytes will address the primary versus secondary effects of W S C F in this regard.
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Increased thrombopoiesis is a frequent feature of the inflammatory response. Inflammatory cytokines such as IL-l and IL-6 may be detected at elevated levels in patients with inflammatory diseases. It appears that marrow megakaryocytes are capable of augmented release of growth-potentiating cytokines in response to the inflammatory mediator ILIp. Thus, augmented thrombopoiesis in such inflammatory conditions may result from the effects of megakaryocytederived cytokines, as well as cytokines derived from other tissue sources.
It appears that the marrow megakaryocyte is more than a mother that simply spawns a multitude of platelets. The marrow megakaryocyte, like the monocyte and T lymphocyte, is capable of releasing a wide repertoire of cytokines that may modulate hematopoiesis and participate in the inflammatory response. Further studies of the regulation of cytokine synthesis and release by the marrow megakaryocyte during physiologic and disease conditions should increase our understanding of the roles that cells of this lineage play in host defense.
